Trial intelligence / Profile preview

PROICA: Saccharomyces boulardii in Heart Failure

NCT01500343Phase 2Completed

Sponsor
Universidade Federal Fluminense
Start
Nov 2008
Primary completion
Mar 2010
Modality
Microbiome Therapeutics
Countries
1
01

Overview

A Phase 2 trial of saccharomyces boulardii in heart failure (HF), sponsored by Universidade Federal Fluminense. Started Nov 2008; status: completed.

02

Drugs

saccharomyces boulardii
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT01500343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01500343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call